Oren Elmaliah
Net worth: 20 150 $ as of 31/05/2026
Net worth: 20 150 $ as of 31/05/2026
Oren Elmaliah currently works at Presstek LLC, as Chief Financial Officer-Israel from 2017, Enlivex Therapeutics Ltd., as Controller from 2017, and My Size, Inc., as Chief Financial Officer from 2025.
Mr. Elmaliah also formerly worked at My Size, Inc., as Independent Director from 2017 to 2025 and Bioblast Pharma Ltd., as Chief Financial Officer & Controller.
Mr. Elmaliah received his undergraduate degree in 2011 from Tel-Aviv University and graduate degree in 2016 from Tel-Aviv University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MY SIZE, INC. 0.67% | 21/05/2026 | 32,500 ( 0.67% ) | 20 150 $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| ENLIVEX LTD. | Comptroller/Controller/Auditor | 01/02/2017 |
| MY SIZE, INC. | Director of Finance/CFO | 01/04/2025 |
Presstek LLC
Presstek LLC Industrial MachineryProducer Manufacturing Manufactures and supplies printing equipment & plates | Corporate Officer/Principal | 01/01/2017 |
| Companies | Position | End |
|---|---|---|
| MY SIZE, INC. | Director/Board Member | 06/03/2025 |
Bioblast Pharma Ltd.
Bioblast Pharma Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Director of Finance/CFO | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Presstek LLC
Presstek LLC Industrial MachineryProducer Manufacturing Manufactures and supplies printing equipment & plates | Producer Manufacturing |
Bioblast Pharma Ltd.
Bioblast Pharma Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
My Size, Inc.
My Size, Inc. Internet Software/ServicesTechnology Services Engages in the development of smart phone application | Technology Services |
Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd. BiotechnologyHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Health Technology |
Select your edition
All financial news and data tailored to specific country editions